U.S. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United StatesJean Anderson, Cheryl Thiemann, Carmen Zorrilla et al.|Unknown|2000Cited by 104
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Kenneth Ngure, Connie Celum et al.|The Lancet HIV|2023Cited by 62
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort StudyKathryn Peebles, Felix Mhlanga, Flavia Matovu Kiweewa et al.|Clinical Infectious Diseases|2020Cited by 44
Characteristics of Multiple and Concurrent Partnerships Among Women At High Risk for HIV InfectionAdaora A. Adimora, Sally Hodder, James P. Hughes et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 33
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083Meredith E. Clement, Richard Novák, Brett Hanscom et al.|Clinical Infectious Diseases|2024Cited by 0